摘要 |
Aerosol formulations suitable for use in pressurised metered dose inhalers comprise a hydrofluoroalkane propellant, an medicament for inhalation and a surfactant which is a a C<SUB>8</SUB>-C<SUB>16 </SUB>fatty acid or salt thereof, a bile salt, a phospholipid, or an alkyl saccharide. |